Skip to contentLAWLOR AUGUSTINE — HUMAN GENOME SCIENCES INC insider: 171 transactions · InsiderLensLAWLOR AUGUSTINE
- Director at REPLIDYNE INC · on record since Jun 30, 2006
- 10% owner at REPLIDYNE INC · on record since Jun 30, 2006
- Director at HUMAN GENOME SCIENCES INC · on record since May 1, 2006
- 10% owner at MEMORY PHARMACEUTICALS CORP · on record since Apr 5, 2004
- 10% owner at ADVANCIS PHARMACEUTICAL CORP · on record since Apr 13, 2007
- member of Section 13(d) group at HEALTHCARE ACQUISITION CORP · on record since Aug 7, 2007
- 10% owner at HEALTHCARE ACQUISITION CORP · on record since Aug 7, 2007
- 10% owner at THRESHOLD PHARMACEUTICALS INC · on record since Sep 8, 2008
- Director at PRF Technologies Ltd. · on record since Mar 18, 2026
- Director at CARDIOVASCULAR SYSTEMS INC · on record since Mar 4, 2009
- 10% owner at CRITICAL THERAPEUTICS INC · on record since May 26, 2004
- 10% owner at MPM ACQUISITION CORP · on record since May 24, 2011
- 10% owner at TETRALOGIC PHARMACEUTICALS CORP · on record since Dec 17, 2013
- 10% owner at TREVENA INC · on record since Jan 30, 2014
- Director at GLOBEIMMUNE INC · on record since Jul 17, 2014
- 10% owner at GLOBEIMMUNE INC · on record since Jul 17, 2014
- Director at GLYCOMIMETICS INC · on record since Aug 20, 2015
- 10% owner at PERFORMANCE TECHNOLOGIES INC \DE\ · on record since Feb 17, 2016
- Chief Operating Officer at LEAP THERAPEUTICS, INC. · on record since Jan 23, 2017
- 10% owner at LEAP THERAPEUTICS, INC. · on record since Jan 23, 2017
Insider trading activity of LAWLOR AUGUSTINE
- Transactions on record
- 171
- since Mar 4, 2004
- Open-market buys
- 3
- $9.5M
- Open-market sells
- 18
- $10.7M
- Companies traded
- 8
- last filing Apr 1, 2025
Figures computed from official regulatory filings — methodology.
Companies where LAWLOR AUGUSTINE has traded
Track record of LAWLOR AUGUSTINE
Statistical track record
Free- Open-market buys
- 5
- Last buy
- Feb 5, 2019
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of LAWLOR AUGUSTINE
Co-insiders of LAWLOR AUGUSTINE
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
GALAKATOS NICHOLASCRITICAL THERAPEUTICS INC +3
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Apr 1, 2025 | ExerciseD | -22,500 | 0.00 USD | $0 | SEC |
| Apr 1, 2025 | Exercise | 22,500 | — | — | SEC |
| Apr 1, 2025 | Other | -7,797 | 0.32 USD | $2.5K | SEC |
| Nov 15, 2024 | OtherD | -2,136 | 0.00 USD | $0 | SEC |
| Nov 15, 2024 | Other | 2,136 | 2.82 USD | $6K | SEC |
| Oct 4, 2024 | AwardD | 85,000 | 0.00 USD | $0 | SEC |
| Jan 31, 2024 | AwardD | 85,000 | 0.00 USD | $0 | SEC |
| Jan 30, 2024 | ExerciseD | -5,000 | 0.00 USD | $0 | SEC |
| Jan 30, 2024 | Exercise | 5,000 | — | — | SEC |
| Sep 1, 2023 | Other | -24.22 | — | — | SEC |
| Sep 1, 2023 | Other | -24.57 | — | — | SEC |
| Aug 25, 2023 | AwardD | 70,000 | 0.00 USD | $0 | SEC |
| Apr 27, 2023 | Other | -25,318 | 20.00 USD | $506.4K | SEC |
| Apr 27, 2023 | Other | -5,022 | 20.00 USD | $100.4K | SEC |
| Apr 27, 2023 | OtherD | -103,719 | 0.00 USD | $0 | SEC |
| Apr 4, 2023 | AwardD | 500,000 | 0.00 USD | $0 | SEC |
| Sep 2, 2022 | AwardD | 200,000 | 0.00 USD | $0 | SEC |
| Aug 9, 2022 | AwardD | 9,064 | 0.00 USD | $0 | SEC |
| Feb 2, 2022 | AwardD | 225,000 | 0.00 USD | $0 | SEC |
| Nov 17, 2021 | Award | 1,222 | 0.00 USD | $0 | SEC |
| Oct 5, 2021 | Award | 5,839 | 0.00 USD | $0 | SEC |
| Aug 11, 2021 | Award | 1,710 | 0.00 USD | $0 | SEC |
| Aug 11, 2021 | AwardD | 3,814 | 0.00 USD | $0 | SEC |
| Jul 2, 2021 | Award | 5,542 | 0.00 USD | $0 | SEC |
| Jul 2, 2021 | AwardD | 14,000 | 0.00 USD | $0 | SEC |